Aqr Capital Management LLC Eiger Bio Pharmaceuticals, Inc. Transaction History

Aqr Capital Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$0.89 - $2.52 $257,773 - $729,875	-289,633 Reduced 59.68%	195,665 $176,000
Q4 2022 Feb 14, 2023	BUY	$1.02 - $7.48 $495,003 - $3.63 Million	485,298 New	485,298 $572,000
Q4 2020 Feb 16, 2021	SELL	$7.98 - $12.29 $198,215 - $305,271	-24,839 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$7.96 - $12.42 $217,666 - $339,624	-27,345 Reduced 52.4%	24,839 $202,000
Q2 2020 Aug 17, 2020	BUY	$5.4 - $13.37 $5,427 - $13,436	1,005 Added 1.96%	52,184 $501,000
Q1 2020 May 15, 2020	BUY	$4.91 - $14.7 $251,288 - $752,331	51,179 New	51,179 $348,000

748K

Ticker EIGR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,966,800
Market Cap $76.1M
Description
Eiger BioPharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of targeted therapies for rare and ultra-rare diseases in the United States and internationally. Its lead product candidate is Lonafarnib, an orally bioavailable, small molecule, which is in Phase III clinical trials to ...

Get notified when there are updates to the investment portfolio of Aqr Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Aqr Capital Management LLC with notifications on news.